--- a
+++ b/clusters/9knumclustersv2/clust_1383.txt
@@ -0,0 +1,91 @@
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration.
+Active infection requiring intravenous (IV) antibiotics
+Active infection requiring intravenous antibiotics within  week of study enrollment (day ).
+Active infection requiring intravenous antibiotics at cycle  day 
+Active systemic infection requiring intravenous antibiotics within  weeks of treatment start
+Patients with any unstable medical issue (including cardiac issues as above, active treatment for symptomatic pulmonary embolism, cerebrovascular accident [CVA], renal or hepatic insufficiency, active infection/sepsis requiring intravenous [IV] antibiotics)
+Ongoing or active infection; the requirement for intravenous (IV) antibiotics is considered active infection
+Ongoing active infection; the requirement for intravenous (IV) antibiotics is considered active infection
+Active infection (infection requiring intravenous antibiotics)
+Active infection requiring intravenous (IV) antibiotics within  days before Day , Cycle 
+Active infection requiring intravenous antibiotics at week  day 
+Active serious infection not controlled by oral or intravenous antibiotics
+Clinically significant active infection requiring intravenous antibiotics (=<  days prior to registration)
+Active infection requiring intravenous antibiotics (must be completed prior to registration)
+Infection requiring intravenous antibiotics that was completed <  week of study enrollment (day ) with the exemption of prophylactic antibiotics for long line insertion or biopsy
+Active infection (requiring oral or intravenous antibiotics or antiviral therapy).
+Active serious infection not controlled by oral or intravenous antibiotics.
+Active infection requiring intravenous antibiotics (antibiotics should have been completed prior to registration)
+Active serious infection not controlled by oral or intravenous antibiotics.
+Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization.
+Clinically significant active infection requiring intravenous antibiotics =<  days prior to registration
+Acute bacterial or fungal infection requiring intravenous antibiotics within  days of enrollment;
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Any uncontrolled active systemic infection requiring intravenous (IV) antibiotics
+Active infection requiring intravenous antibiotics
+Evidence of ongoing or active infection requiring intravenous antibiotics;
+Active infection requiring intravenous antibiotics within  days before enrollment
+Severe, active comorbidity, defined as follows:\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Active Crohns disease or ulcerative colitis\r\n* Scleroderma
+Active infection requiring intravenous antibiotics at the time of registration
+Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least  days prior to registration
+Unstable systemic disease in the opinion of the treating physician, for example active infection requiring intravenous (IV) antibiotics
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Serious active infection requiring intravenous (IV) antibiotics
+Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least  days prior to registration
+Patients should be free of active infection requiring intravenous antibiotics
+Active serious infection not controlled by oral or intravenous antibiotics
+Patients must be free of systemic infection requiring intravenous (IV) antibiotics at the time of registration; patients must be off IV antibiotics for at least  days prior to registration
+Active infection requiring oral or intravenous antibiotics
+Patients with active chronic or current infections requiring oral or intravenous antibiotics are NOT eligible for enrollment to the study until resolution of the infection and completion of therapeutic antibiotics
+Active clinically serious infection requiring intravenous antibiotics at the time of study entry (CTCAE Grade )
+Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization.
+Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization
+Serious infection requiring treatment with intravenous antibiotics at the time of study entrance, or an infection requiring intravenous therapy within  days prior.
+Serious infection requiring hospitalization or intravenous (IV) antibiotics within  days prior to enrollment
+Active infection requiring intravenous antibiotics
+At least  days beyond any infection requiring intravenous antibiotic use (Oral\n             antibiotics may be administered prophylactically as clinically indicated)
+Patients have an active infection and require intravenous (IV) or oral antibiotics
+Receipt of intravenous antibiotics for infection within  days prior to enrollment
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Patients with active infection and requiring intravenous (IV) or oral antibiotics
+Serious active infection requiring intravenous (i.v.) antibiotics at enrollment
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Patients must not have uncontrolled active systemic infection requiring intravenous antibiotics
+Patients with active systemic infection requiring intravenous antibiotics
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration or within  weeks of cycle  day .
+Serious active infection requiring intravenous antibiotics and/or hospitalization at study entry
+Any infection requiring ongoing intravenous antibiotics for management
+Patient has evidence of a serious active infection (e.g., infection requiring treatment with intravenous antibiotics).
+Active infection requiring intravenous (IV) antibiotics or other uncontrolled intercurrent illness requiring hospitalization
+Have an ongoing or active infection. The requirement for intravenous (IV) antibiotics is considered active infection.
+Serious infection requiring treatment with intravenous antibiotics at the time of study entrance, or an infection requiring intravenous therapy within  days prior to the first dose of study treatment.
+Receipt of intravenous (IV) antibiotics for infection within  days prior to enrollment into the study
+Patients with active infection and requiring intravenous (IV) or oral antibiotics
+Infection requiring intravenous antibiotics within  days before the first dose of study drug
+Concurrent severe and/or uncontrolled medical disease including, but not limited to, ongoing or active infection requiring intravenous antibiotics, bowel obstruction
+Concurrent severe and/or uncontrolled medical disease including, but not limited to, ongoing or active infection requiring intravenous antibiotics
+Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection requiring intravenous antibiotics
+Active infection, uncontrolled with intravenous antibiotics
+Patients with active infection requiring intravenous (IV) antibiotics within  weeks of registration
+Active serious infection not controlled by oral or intravenous antibiotics
+Patients have an active infection and require intravenous (IV) or oral antibiotics
+Active infection requiring intravenous antibiotics
+Active infection requiring intravenous (IV) antibiotics
+Any uncontrolled active systemic infection that requires treatment with intravenous (IV) antibiotics
+Presence of an infection that requires intravenous antibiotics
+Active infection requiring intravenous antibiotics.
+Current acute infection requiring intravenous antibiotics
+Uncontrolled medical illness such as infection requiring intravenous antibiotics
+Active infection requiring intravenous (IV) antibiotics
+Known active infection requiring intravenous (IV) or oral anti-infective treatment
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+History of any infection requiring hospitalization or intravenous antibiotics within  weeks before enrollment.
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration.
+Use of intravenous antibiotics within the last  months
+Serious concomitant medical condition that could interfere with the conduct of the clinical trial, such as unstable angina, renal failure requiring hemodialysis, or active infection requiring intravenous (IV) antibiotics
+Diagnosis of an infection requiring intravenous (IV) antibiotics  days prior to registration
+Active infection requiring oral or intravenous antibiotics
+The participant has an active infection (requiring intravenous [IV] antibiotics), including tuberculosis.
+Acute bacterial or fungal infection requiring intravenous antibiotics at the time of randomization